Cybis 10:25 Released

Cymra’s flagship clinical product Cybis is now released an on the market through our distributor. Its Australian grown cannabis under Good Agricultural Practice and Australian manufactured under Good Manufacturing Practice.

Full spectrum profile with Linalool the dominant terpene, alongside bisabolol and betacaryophellene providing potential benefits of the entourage effects. Linalool has shown to reduce anxiety through human clinical trials.

Formulation: 

10mg THC

25mg CBD

1mg Linalool

This formulation is specifically formulated for chronic pain patients. However, please consult your doctor to understand if cannabis is the right medication for you.

 

We have a registered clinical trial which is a dose escalation study assessing cannabis as a 2nd line therapy prior to opiate medications. We hope to prove that cannabis is a better alternative for long term chronic pain patients than opiates.

SHARE:
Share on facebook
Share on twitter
Share on linkedin
Share on reddit
Share on email
Share on whatsapp